A study on hereditary angioedema warns about the inequality in access to innovative medications in Portugal, highlighting that although central hospitals already provide these options, smaller units still rely on older therapies with significant side effects. #MedicamentosInovadores #AcessoÀSaúde #AngioedemaHereditário (translated)
